S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Salix, Cosmo cancel merger amid inversion crackdown|
|Crocodile Gold Reports Strong Operating Cash Flow of $18.2 Million on Revenue of $73.3 Million in Q3 2014|
|Crocodile Gold Produces 163,516 Ounces of Gold in First Nine Months of 2014 and Raises Annual Production Guidance to 220,000-225,000 Ounces of Gold|
|INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Salix Pharmaceuticals, Ltd. of Class Action Against Its Board of Directors In Connection With the Sale of the Company to Cosmo Technologies Limited -- SLXP|
|Salix Submits Response to XIFAXAN® 550mg Complete Response Letter Regarding Repeat Treatment for Irritable Bowel Syndrome with Diarrhea|
|Salix Pharmaceuticals Reports 3Q2014 Results|
|Salix Announces FDA User Fee Goal Date of February 28, 2015 for XIFAXAN® 550mg sNDA for Treatment of Irritable Bowel Syndrome with Diarrhea|
|Salix Secures Additional Intellectual Property Relating to Rifaximin|
|FDA Approves RELISTOR® Subcutaneous Injection for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-cancer Pain|
|UPDATE: What could scare markets over upcoming earnings, and Buffett's onto something (2014/10/3)|
Click above to view more mutual fund data and stats for cosmo - Cosmos Yatirim Holding AS.